IP Library Granted Patent US 8,153,685
Granted Patent B2
US 8,153,685 · App. 11/885,375 · Granted Apr 10, 2012

Salts, addition compounds and complex compounds of guinadinoacetic acid

Assignee: Alzchem Trostberg GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,153,685
App. No.
11/885,375
Granted
Apr 10, 2012
Kind
B2
Abstract

The present invention provides new salts and/or addition compounds and/or complex compounds of guanidinoacetic acid with malic acid, aspartic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, α-ketoglutaric acid, oxalic acid, pyroglutamic acid, 3-nicotinic acid, lactic acid, citric acid, maleic acid, sulfuric acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline, methionine and lipoic acid as well as in the form of sodium, potassium or calcium guanidinoacetate. These salts have improved physiological and therapeutic properties and are particularly suitable for use as dietary supplements, as animal feeds and in cosmetic or dermatological preparations in which especially the marked stability and good bioavailability of the salts come to the fore.

Claims (30)

1. A method comprising increasing creatine in the muscle of a subject by administering to said subject a composition comprising at least one guanidinoacetic acid salt comprising (i) guanidinoacetic acid and (ii) malic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, α-ketoglutaric acid, oxalic acid, pyroglutamic acid, 3-nicotinic acid, citric acid, maleic acid, sulfuric acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline or lipoic acid.

2. The method of claim 1 , wherein said composition further comprises at least one additional substance selected from the group consisting of carbohydrates, fats, amino acids, proteins, vitamins, mineral substances, trace elements, derivatives thereof and mixtures thereof.

3. The method of claim 1 , wherein said composition is in the form of a powder, a granulate, a lozenge, a capsule, a pellet, a solution, a fruit juice or a jelly product.

4. The method of claim 1 , wherein a sufficient amount of said composition is administered in an amount sufficient to provide a single dose of 0.001 to 1 g/kg of at least one guanidinoacetic acid salt or addition or complex compound per body weight of said subject.

5. The method of claim 1 , wherein a sufficient amount of said composition is administered to the subject to provide a single dose of 0.001 to 50 g of said at least one guanidinoacetic acid salt.

6. The method of claim 1 , wherein said subject is a mammal.

7. The method of claim 6 , wherein said mammal is a human, dog, cat, pig, or horse.

8. The method of claim 1 , wherein the subject is a chicken.

9. The method of claim 1 , wherein said subject is a human that attends school, plays sports, is a convalescent, or is a geriatric.

10. A method comprising increasing muscle mass of a subject by administering to said subject a composition comprising at least one guanidinoacetic acid salt comprising (i) guanidinoacetic acid and (ii) malic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, α-ketoglutaric acid, oxalic acid, pyroglutamic acid, 3-nicotinic acid, citric acid, maleic acid, sulfuric acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline or lipoic acid.

11. A method comprising increasing the bioavailability of guanidinoacetic acid in a subject by administering to said subject a composition comprising at least one guanidinoacetic acid salt comprising (i) guanidinoacetic acid and (ii) malic acid, ascorbic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, α-ketoglutaric acid, oxalic acid, pyroglutamic acid, 3-nicotinic acid, citric acid, maleic acid, sulfuric acid, acetic acid, formic acid, 2-hydroxybenzoic acid, L-carnitine, acetyl-L-carnitine, taurine, betaine, choline or lipoic acid.

12. An animal feed or dietary supplement comprising at least one guanidinoacetic acid salt comprising (i) guanidinoacetic acid and (ii) at least one acid selected from the group consisting aspartic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, α-ketoglutaric acid, pyroglutamic acid, citric acid, maleic acid, sulfuric acid, acetic acid, formic acid and lipoic acid.

13. The animal feed or dietary supplement according to claim 12 , wherein the at least one acid is selected from the group consisting of succinic acid, pyruvic acid, fumaric acid, gluconic acid, α-ketoglutaric acid, pyroglutamic acid, citric acid, maleic acid, sulfuric acid, acetic acid, formic acid and lipoic acid.

14. A method comprising increasing creatine in the muscle of a subject by administering to said subject a sufficient amount of the animal feed or dietary supplement of claim 12 , to increase creatine in said muscle of said subject.

15. A method comprising increasing creatine in the muscle of a subject by administering to said subject a sufficient amount of the animal feed or dietary supplement of claim 13 , to increase creatine in said muscle of said subject.

16. A method comprising increasing creatine in the muscle of an animal by administering to said animal a sufficient amount of an animal feed, to increase creatine in said muscle of said animal, wherein said animal feed comprises at least one guanidinoacetic acid salt comprising (i) guanidinoacetic acid and (ii) at least one acid selected from the group consisting of aspartic acid, succinic acid, pyruvic acid, fumaric acid, gluconic acid, α-ketoglutaric acid, pyroglutamic acid, citric acid, maleic acid, sulfuric acid, acetic acid, formic acid and lipoic acid.

17. The method according to claim 16 , wherein the at least one acid is selected from the group consisting of succinic acid, pyruvic acid, fumaric acid, gluconic acid, α-ketoglutaric acid, pyroglutamic acid, citric acid, maleic acid, sulfuric acid, acetic acid, formic acid and lipoic acid.

18. The method of claim 14 , wherein the animal feed or dietary supplement further comprises at least one additional substance selected from the group consisting of carbohydrates, fats, amino acids, proteins, vitamins, mineral substances, trace elements, derivatives thereof and mixtures thereof.

19. The method of claim 14 , wherein said animal feed or dietary supplement is in the form of a powder, a granulate, a lozenge, a capsule, a pellet, a solution, a fruit juice or a jelly product.

20. The method of claim 14 , wherein a sufficient amount of said composition is administered in an amount sufficient to provide a single dose of 0.001 to 1 g/kg of said at least one guanidinoacetic acid salt per body weight of said subject.

21. The method of claim 14 , wherein a sufficient amount of said composition is administered to the subject to provide a single dose of 0.001 to 50 g of said at least one guanidinoacetic acid salt.

22. The method of claim 16 , wherein said subject is a mammal.

23. The method of claim 16 , wherein said animal is a dog, cat, pig, or horse.

24. The method of claim 16 , wherein said animal is a chicken.

25. The method of claim 14 , wherein said subject is a human that attends school, plays sports, is a convalescent, or is a geriatric.

26. The method of claim 15 , wherein said subject is a human that attends school, plays sports, is a convalescent, or is a geriatric.

27. The method of claim 15 , wherein the animal feed or dietary supplement further comprises at least one additional substance selected from the group consisting of carbohydrates, fats, amino acids, proteins, vitamins, mineral substances, trace elements, derivatives thereof and mixtures thereof.

28. The method of claim 15 , wherein said animal feed or dietary supplement is in the form of a powder, a granulate, a lozenge, a capsule, a pellet, a solution, a fruit juice or a jelly product.

29. The method of claim 15 , wherein a sufficient amount of said composition is administered in an amount sufficient to provide a single dose of 0.001 to 1 g/kg of at least one guanidinoacetic acid salt per body weight of said subject.

30. The method of claim 15 , wherein a sufficient amount of said composition is administered to the subject to provide a single dose of 0.001 to 50 g of said at least one guanidinoacetic acid salt.

Assignments (3)
CHANGE OF NAME Recorded Jul 31, 2018
From: ALZCHEM AG
To: ALZCHEM TROSTBERG GMBH
Reel/Frame 046670/0167 →
CHANGE OF NAME Recorded Apr 18, 2013
From: ALZCHEM TROSTBERG GMBH
To: ALZCHEM AG
Reel/Frame 030241/0592 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2008
From: GASTNER, THOMAS; KRIMMER, HANS-PETER
To: ALZCHEM TROSTBERG GMBH
Reel/Frame 020620/0550 →
Priority Claims (1)
DE 10 2005 009 990 · Mar 4, 2005 · national
Continuity (1)
Related Publication 20080161387A1 · Jul 3, 2008